Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000539082 | SCV000658529 | likely benign | Familial hyperkalemic periodic paralysis | 2023-07-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001548373 | SCV001768270 | uncertain significance | not provided | 2021-01-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002526745 | SCV003726749 | uncertain significance | Inborn genetic diseases | 2022-03-29 | criteria provided, single submitter | clinical testing | The c.2200G>T (p.A734S) alteration is located in exon 13 (coding exon 13) of the SCN4A gene. This alteration results from a G to T substitution at nucleotide position 2200, causing the alanine (A) at amino acid position 734 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001548373 | SCV003821306 | uncertain significance | not provided | 2021-07-06 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001548373 | SCV004224424 | uncertain significance | not provided | 2023-02-23 | criteria provided, single submitter | clinical testing | BP4 |